KALA BIO, Inc. short interest in 2025
In 2025, KALA BIO, Inc.'s disclosed short interest ran from 0.32% of shares outstanding on 15 Jan 2025 to 6.71% on 31 Dec 2025, a change of +6.39 percentage points. The year's high was 26.80% on 28 Nov 2025 and its low 0.32% on 15 Jan 2025, averaging 7.31% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.56 days on 31 Mar 2025. Full history: KALA BIO, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 0.32% (15 Jan 2025)
- End of year
- 6.71% (31 Dec 2025)
- Change
- +6.39 pp
- High
- 26.80% (28 Nov 2025)
- Low
- 0.32% (15 Jan 2025)
- Average
- 7.31%
- Highest days to cover
- 13.56 (31 Mar 2025)
- SEC filings marked
- 7
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 0.32% | 1.00 | |
| 31 Mar 2025 | 4.12% | 13.56 | 10-K filed, results (8-K) |
| 15 Apr 2025 | 4.38% | 4.90 | |
| 30 Apr 2025 | 6.27% | 3.61 | |
| 15 May 2025 | 4.45% | 3.99 | 10-Q filed, results (8-K) |
| 30 May 2025 | 4.56% | 8.25 | |
| 13 Jun 2025 | 4.59% | 5.43 | |
| 30 Jun 2025 | 4.80% | 4.09 | |
| 15 Jul 2025 | 4.96% | 1.77 | |
| 31 Jul 2025 | 5.40% | 1.49 | |
| 15 Aug 2025 | 5.68% | 4.15 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 5.98% | 2.40 | |
| 15 Sep 2025 | 9.27% | 1.68 | |
| 15 Oct 2025 | 12.72% | 1.00 | |
| 31 Oct 2025 | 9.91% | 1.00 | |
| 14 Nov 2025 | 6.61% | 2.70 | |
| 28 Nov 2025 | 26.80% | 1.00 | 10-Q filed |
| 15 Dec 2025 | 11.31% | 1.00 | |
| 31 Dec 2025 | 6.71% | 1.00 |
See also: KALA BIO, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.